Related references
Note: Only part of the references are listed.Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
N-Acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro
Melani Sooriyaarachchi et al.
METALLOMICS (2013)
Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect
Jane A. Plumb et al.
METALLOMICS (2012)
The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro
Melani Sooriyaarachchi et al.
METALLOMICS (2012)
Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro
Melani Sooriyaarachchi et al.
METALLOMICS (2011)
Advances in Platinum Chemotherapeutics
Benjamin W. Harper et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Unusual DNA binding modes for metal anticancer complexes
Ana M. Pizarro et al.
BIOCHIMIE (2009)
Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
Katherine S. Lovejoy et al.
DALTON TRANSACTIONS (2009)
Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography-inductively coupled plasma atomic emission spectroscopy
Shawn A. Manley et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Polymeric Drug Delivery of Platinum-Based Anticancer Agents
Katherine J. Haxton et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
New trends for metal complexes with anticancer activity
Pieter C. A. Bruijnincx et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Substituted β-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators
Anwen M. Krause-Heuer et al.
INORGANIC CHEMISTRY (2008)
Selection of agents for prevention of cisplatin-induced hepatotoxicity
Yingjun Liao et al.
PHARMACOLOGICAL RESEARCH (2008)
Distinct mechanisms for ctr1-mediated copper and cisplatin transport
Devis Sinani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Prevention of noise- and drug-induced hearing loss with D-methionine
Kathleen C. M. Campbell et al.
HEARING RESEARCH (2007)
Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the eleventh annual blood-brain barrier consortium meeting
Nancy D. Doolittle et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels
DT Dickey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway
YJ Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Y Li et al.
EUROPEAN JOURNAL OF CANCER (2004)
Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity
C Wimmer et al.
OTOLOGY & NEUROTOLOGY (2004)
Round window application of D-methionine provides complete cisplatin otoprotection
KD Korver et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2002)
D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics
A Ekborn et al.
HEARING RESEARCH (2002)
Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy
GM Li et al.
NEUROTOXICOLOGY (2001)
Glutathione readily replaces the thioether on platinum in the reaction with [Pt(dien)(GSMe)](2+) (GSMe = S-methylated glutathione); a model study for cisplatin-protein interactions
JM Teuben et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
Share Paper
